rs121918611
Variant summary
Our verdict is Likely pathogenic. The variant received 6 ACMG points: 6P and 0B. PM1PM2PP3_Moderate
The NM_003052.5(SLC34A1):c.439G>A(p.Val147Met) variant causes a missense change. The variant allele was found at a frequency of 0.0000031 in 1,614,092 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V147L) has been classified as Uncertain significance.
Frequency
Consequence
NM_003052.5 missense
Scores
Clinical Significance
Conservation
Publications
- hypercalcemia, infantile, 2Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, ClinGen
- dominant hypophosphatemia with nephrolithiasis or osteoporosisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- primary Fanconi syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- autosomal recessive infantile hypercalcemiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- hypophosphatemic nephrolithiasis/osteoporosis 1Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- Fanconi renotubular syndrome 2Inheritance: AR Classification: LIMITED, NO_KNOWN Submitted by: ClinGen, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 6 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SLC34A1 | ENST00000324417.6 | c.439G>A | p.Val147Met | missense_variant | Exon 5 of 13 | 1 | NM_003052.5 | ENSP00000321424.4 | ||
| SLC34A1 | ENST00000512593.5 | c.439G>A | p.Val147Met | missense_variant | Exon 5 of 9 | 2 | ENSP00000423022.1 | |||
| SLC34A1 | ENST00000507685.5 | n.523G>A | non_coding_transcript_exon_variant | Exon 5 of 10 | 2 | |||||
| SLC34A1 | ENST00000504577.5 | c.*183G>A | downstream_gene_variant | 4 | ENSP00000423733.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152230Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00000795 AC: 2AN: 251438 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1461862Hom.: 0 Cov.: 34 AF XY: 0.00000275 AC XY: 2AN XY: 727238 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152230Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74358 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Hypophosphatemic nephrolithiasis/osteoporosis 1 Pathogenic:1
- -
not provided Uncertain:1
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies have shown that this missense change affects SLC34A1 function (PMID: 12324554, 14672348). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). ClinVar contains an entry for this variant (Variation ID: 12932). This missense change has been observed in individual(s) with demineralization and hypophosphatemia (PMID: 12324554). This variant is present in population databases (rs121918611, gnomAD 0.002%). This sequence change replaces valine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 147 of the SLC34A1 protein (p.Val147Met). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at